Free Trial

CVS Health Co. (NYSE:CVS) is Aquatic Capital Management LLC's 10th Largest Position

CVS Health logo with Medical background

Aquatic Capital Management LLC boosted its stake in shares of CVS Health Co. (NYSE:CVS - Free Report) by 258.1% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 751,948 shares of the pharmacy operator's stock after acquiring an additional 541,948 shares during the quarter. CVS Health comprises about 0.9% of Aquatic Capital Management LLC's investment portfolio, making the stock its 10th biggest position. Aquatic Capital Management LLC owned 0.06% of CVS Health worth $33,755,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently added to or reduced their stakes in the company. Morse Asset Management Inc acquired a new position in CVS Health in the 3rd quarter worth about $409,000. Westside Investment Management Inc. grew its position in CVS Health by 4.6% in the third quarter. Westside Investment Management Inc. now owns 64,517 shares of the pharmacy operator's stock worth $4,041,000 after acquiring an additional 2,856 shares during the period. World Investment Advisors LLC raised its stake in shares of CVS Health by 280.7% in the 3rd quarter. World Investment Advisors LLC now owns 27,543 shares of the pharmacy operator's stock valued at $1,732,000 after acquiring an additional 20,308 shares during the period. Wilmington Savings Fund Society FSB purchased a new stake in shares of CVS Health in the 3rd quarter valued at approximately $2,071,000. Finally, Tidal Investments LLC raised its stake in shares of CVS Health by 52.2% in the 3rd quarter. Tidal Investments LLC now owns 112,010 shares of the pharmacy operator's stock valued at $7,043,000 after acquiring an additional 38,408 shares during the period. 80.66% of the stock is owned by institutional investors.

CVS Health Stock Performance

NYSE CVS traded up $4.19 during trading on Thursday, hitting $70.90. 12,455,066 shares of the company's stock traded hands, compared to its average volume of 11,837,954. CVS Health Co. has a 12-month low of $43.56 and a 12-month high of $73.54. The stock has a market capitalization of $89.39 billion, a price-to-earnings ratio of 19.42, a PEG ratio of 0.98 and a beta of 0.57. The company has a debt-to-equity ratio of 0.80, a quick ratio of 0.60 and a current ratio of 0.81. The business has a 50 day moving average of $66.51 and a 200-day moving average of $58.80.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The pharmacy operator reported $2.25 EPS for the quarter, beating analysts' consensus estimates of $1.62 by $0.63. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. The business had revenue of $94.59 billion for the quarter, compared to analysts' expectations of $93.07 billion. During the same period last year, the business earned $1.31 earnings per share. The business's quarterly revenue was up 7.0% on a year-over-year basis. As a group, equities research analysts anticipate that CVS Health Co. will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 1st. Stockholders of record on Tuesday, April 22nd will be paid a $0.665 dividend. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 annualized dividend and a dividend yield of 3.75%. CVS Health's dividend payout ratio is presently 72.68%.

Insider Activity at CVS Health

In other CVS Health news, Director Michael F. Mahoney purchased 30,000 shares of CVS Health stock in a transaction dated Tuesday, February 18th. The shares were purchased at an average cost of $66.70 per share, for a total transaction of $2,001,000.00. Following the completion of the acquisition, the director now owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, SVP James David Clark sold 7,513 shares of the stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total value of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares in the company, valued at $556,941.90. This trade represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. 1.22% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts have commented on the stock. Leerink Partners upgraded shares of CVS Health from a "market perform" rating to an "outperform" rating and boosted their price target for the stock from $55.00 to $75.00 in a report on Thursday, February 13th. UBS Group decreased their price target on shares of CVS Health from $62.00 to $59.00 and set a "neutral" rating for the company in a research note on Tuesday, February 11th. Robert W. Baird increased their price target on shares of CVS Health from $51.00 to $71.00 and gave the stock a "neutral" rating in a research note on Tuesday, April 15th. Morgan Stanley restated an "overweight" rating on shares of CVS Health in a research report on Tuesday, April 15th. Finally, Piper Sandler raised their price objective on shares of CVS Health from $72.00 to $74.00 and gave the company an "overweight" rating in a research note on Friday, March 21st. Four equities research analysts have rated the stock with a hold rating, eighteen have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $71.83.

View Our Latest Stock Report on CVS Health

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

See Also

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Should You Invest $1,000 in CVS Health Right Now?

Before you consider CVS Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.

While CVS Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

5 Stocks to BUY NOW in May 2025
3 Stocks Offering Rare Generational Buying Opportunities
Make Your Money Work Harder: The Power of Dividend Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines